Skip to content

Clinical trials

Bronchiectasis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiectasis Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20113
20121
20131
20141
20161
20182
20191
20201
20211
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status5
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Gilead Sciences2
Aradigm Corporation1
AstraZeneca1
Dr. Grace Parraga1
McMaster University1
National Heart, Lung, and Blood Institute (NHLBI)1
Neovii Biotech1
Sanofi1
SolAeroMed Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiectasis20
Cystic Fibrosis5
Pulmonary Disease, Chronic Obstructive4
Asthma3
Bronchial Diseases2
Emphysema2
Lung Neoplasms2
Pulmonary Embolism2
Pulmonary Fibrosis2
Respiratory Tract Diseases2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.